rethinkPeptides Search
Menu
Research citation

Development of a potent Xenopus GLP-1-derived GLP-1/GIP/Y2 receptor tri-agonist for obesity and type 2 diabetes.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Development of a potent Xenopus GLP-1-derived GLP-1/GIP/Y2 receptor tri-agonist for obesity and type 2 diabetes.

International journal of biological macromolecules, 328(Pt 1), 147553

Citation

Liu, Xiyu; Gong, Binbin; Wang, Ting; Hu, Guoqiang; Han, Jing; Sun, Lidan. (2025). Development of a potent Xenopus GLP-1-derived GLP-1/GIP/Y2 receptor tri-agonist for obesity and type 2 diabetes.. International journal of biological macromolecules, 328(Pt 1), 147553. https://doi.org/10.1016/j.ijbiomac.2025.147553